Home / Stocks / ALNY

ALNY insider trading

ALNYLAM PHARMACEUTICALS, INC. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
1
Bought · 24 mo
$10k
Buys · last 90 days
0 · $0
Most recent buy
2025-05-12

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-02-17Greenstreet Yvonne
Chief Executive Officer
Sold6,958$310.08$2.2M
2025-11-19Fitzgerald Kevin Joseph
CSO & EVP, Head of Research
Sold8,168$449.00$3.7M
2025-11-14Greenstreet Yvonne
Chief Executive Officer
Sold5,826$456.01$2.7M
2025-09-11Reitan Colleen F
Director
Sold2,290$461.92$1.1M
2025-08-19Greenstreet Yvonne
Chief Executive Officer
Sold2,716$454.04$1.2M
2025-08-19BONNEY MICHAEL W
Director
Sold11,250$450.00$5.1M
2025-08-15Ausiello Dennis A
Director
Sold18,335$436.69$8.0M
2025-06-03Greenstreet Yvonne
Chief Executive Officer
Sold50,937$305.00$15.5M
2025-05-12Reitan Colleen F
Director
Bought36$287.85$10k
2025-03-25Garg Pushkal
CMO & EVP Dev & Med Affairs
Sold9,766$293.36$2.9M
2025-03-25PYOTT DAVID E I
Director
Sold7,440$299.00$2.2M
2025-01-29Garg Pushkal
CMO & EVP Dev & Med Affairs
Sold52,592$285.00$15.0M
2025-01-24SHARP PHILLIP A
Director
Sold11,250$275.00$3.1M

Most active insider buyers

InsiderRoleBuysTotal bought
Reitan Colleen FDirector1$10k

See ALNY on the chart

Every insider buy and sell for ALNY plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.